Our Experience
Da Vinci Study – Amgen
Registry with 1 year retrospective data collection from a cross-sectional cohort of CHD/PVD/PP/Stroke patients
Aim: to estimate the proportion of patients in Europe with an LDL-C above 2016 ESC guidelines
- 18 countries
- 6000 Patients
- 132 investigator sites
- Full service delivery in-house at ICTU
- 2.5 years from setup – archiving
- 18 month recruitment period
Results: Among patients receiving LLT fewer than half of high/very high-risk primary and secondary prevention patients achieved 2016 LDL-C goals, with approximately one-fifth achieving the lower 2019 goals